Literature DB >> 12118852

Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse.

Xiao-Chun Xu1, Jeremy Goodman, Hitomi Sasaki, Jeffrey Lowell, T Mohanakumar.   

Abstract

The rejection of xenografts is characterized by infiltration of monocytes and natural killer (NK) cells into the graft, suggesting an important role for the innate immune system in xenorecognition. In this study, purified human NK or T cells were cocultured with porcine endothelial cells, and cytokines were analyzed by ELISA and intracellular FACS. We demonstrated a vigorous human anti-porcine xenoresponse that was associated with a strong T-cell proliferation against porcine endothelial cells. Limiting dilution cloning and T-cell receptor (TCR) Vbeta gene usage revealed a low number of xenoreactive T-cell precursors. We demonstrated that xenogeneic porcine but not allogeneic human endothelial cells induced the early production of interferon (IFN)-gamma by human NK cells but not by CD3+ T cells. Porcine xenoantigen-induced IFN-gamma production was only partially dependent on IL-12. Blocking IL-12 with neutralizing antibodies or by depletion of human macrophages partially decreased IFN-gamma production by CD56+ NK cells. Three-color flow cytometry revealed that IL-12 was produced through a species-specific activation of human macrophages by porcine endothelial cells. Our results indicate that the direct activation of NK cells and macrophages by porcine endothelial cells provides a unique pathway of xenorecognition that augments downstream specific T-cell immunity and represents a powerful effector mechanism in xenograft rejection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118852     DOI: 10.1034/j.1600-6143.2002.20405.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

2.  Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A.

Authors:  Chiyoshi Toyama; Akira Maeda; Shuhei Kogata; Riho Yamamoto; Kazunori Masahata; Takehisa Ueno; Masafumi Kamiyama; Yuko Tazuke; Hiroshi Eguchi; Hiroomi Okuyama; Shuji Miyagawa
Journal:  Exp Ther Med       Date:  2022-07-26       Impact factor: 2.751

Review 3.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

4.  Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses.

Authors:  Yih-Jyh Lin; Hidetaka Hara; Hao-Chih Tai; Cassandra Long; Daisuke Tokita; Peter Yeh; David Ayares; Adrian E Morelli; David K C Cooper
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

Review 5.  The Innate Cellular Immune Response in Xenotransplantation.

Authors:  Akira Maeda; Shuhei Kogata; Chiyoshi Toyama; Pei-Chi Lo; Chizu Okamatsu; Riho Yamamoto; Kazunori Masahata; Masafumi Kamiyama; Hiroshi Eguchi; Masahito Watanabe; Hiroshi Nagashima; Hiroomi Okuyama; Shuji Miyagawa
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration.

Authors:  Lauren Scarfe; Arthur Taylor; Jack Sharkey; Rachel Harwood; Michael Barrow; Joan Comenge; Lydia Beeken; Cai Astley; Ilaria Santeramo; Claire Hutchinson; Lorenzo Ressel; Jon Smythe; Eric Austin; Raphael Levy; Matthew J Rosseinsky; Dave J Adams; Harish Poptani; Brian K Park; Patricia Murray; Bettina Wilm
Journal:  Stem Cell Res Ther       Date:  2018-11-28       Impact factor: 6.832

7.  HLA-G1+ Expression in GGTA1KO Pigs Suppresses Human and Monkey Anti-Pig T, B and NK Cell Responses.

Authors:  Joseph Sushil Rao; Nora Hosny; Ramesh Kumbha; Raza Ali Naqvi; Amar Singh; Zachary Swanson; Heather Levy; Anders W Matson; Magie Steinhoff; Nicole Forneris; Eric Walters; Bernhard J Hering; Christopher Burlak
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.